These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Primary pulmonary hypertension: clinical, echocardiographic and haemodynamic features in 14 patients. Islam MN; Bashar MA; Zafar A Bangladesh Med Res Counc Bull; 1993 Dec; 19(3):113-27. PubMed ID: 8031285 [TBL] [Abstract][Full Text] [Related]
3. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. D'Alonzo GE; Barst RJ; Ayres SM; Bergofsky EH; Brundage BH; Detre KM; Fishman AP; Goldring RM; Groves BM; Kernis JT Ann Intern Med; 1991 Sep; 115(5):343-9. PubMed ID: 1863023 [TBL] [Abstract][Full Text] [Related]
4. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. Baughman RP; Shlobin OA; Wells AU; Alhamad EH; Culver DA; Barney J; Cordova FC; Carmona EM; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Kouranos V; O'Hare L; Baran JM; Cal JG; Lower EE; Engel PJ; Nathan SD Respir Med; 2018 Jun; 139():72-78. PubMed ID: 29858005 [TBL] [Abstract][Full Text] [Related]
5. Does reduced lung diffusing capacity for carbon monoxide predict the presence of pulmonary hypertension? Delcour KS; Singla A; Jarbou M; Alpert M; Dabbagh O Am J Med Sci; 2010 Jul; 340(1):54-9. PubMed ID: 20463574 [TBL] [Abstract][Full Text] [Related]
6. Clinical features of paediatric pulmonary hypertension: a registry study. Berger RM; Beghetti M; Humpl T; Raskob GE; Ivy DD; Jing ZC; Bonnet D; Schulze-Neick I; Barst RJ Lancet; 2012 Feb; 379(9815):537-46. PubMed ID: 22240409 [TBL] [Abstract][Full Text] [Related]
7. Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension). Beghetti M; Schulze-Neick I; Berger RM; Ivy DD; Bonnet D; Weintraub RG; Saji T; Yung D; Mallory GB; Geiger R; Berger JT; Barst RJ; Humpl T; Int J Cardiol; 2016 Jan; 203():325-30. PubMed ID: 26583838 [TBL] [Abstract][Full Text] [Related]
8. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide. Rose L; Prins KW; Archer SL; Pritzker M; Weir EK; Misialek JR; Thenappan T J Heart Lung Transplant; 2019 Feb; 38(2):145-155. PubMed ID: 30391191 [TBL] [Abstract][Full Text] [Related]
17. The frequency of pulmonary hypertension in patients with juvenile scleroderma. Adrovic A; Oztunc F; Barut K; Koka A; Gojak R; Sahin S; Demir T; Kasapcopur O Bosn J Basic Med Sci; 2015 Aug; 15(4):30-5. PubMed ID: 26614849 [TBL] [Abstract][Full Text] [Related]
18. [Primary or of unknown etiology pulmonary hypertension: survival and its determinants]. Sandoval Zárate J Gac Med Mex; 1994; 130(6):465-75. PubMed ID: 7557062 [TBL] [Abstract][Full Text] [Related]
19. Isolated diffusing capacity reduction in systemic sclerosis. Steen VD; Graham G; Conte C; Owens G; Medsger TA Arthritis Rheum; 1992 Jul; 35(7):765-70. PubMed ID: 1622414 [TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of tricuspid valve regurgitation in pulmonary arterial hypertension. Chen L; Larsen CM; Le RJ; Connolly HM; Pislaru SV; Murphy JG; McGoon MD; Frantz RP; Kane GC Clin Respir J; 2018 Apr; 12(4):1572-1580. PubMed ID: 28905517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]